Illumina, Inc. (ILMN) stock
ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 14/3013% above fair value
$202.61+4.61 (+2.33%)
Close on Nov 17, 2026Market cap $30.63BP/E 34.8Yield –
Illumina total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Illumina's total debt was $1.79B at Sep 27, 2026. For fiscal 2025 it was $1.49B, up 0.0% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $2.00B in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $1.49B | 0.0% |
| FY2024 | Dec 29, 2024 | $1.49B | +0.1% |
| FY2023 | Dec 31, 2023 | $1.49B | +0.1% |
| FY2022 | Jan 1, 2023 | $1.49B | +49.7% |
| FY2021 | Jan 2, 2022 | $993.00M | -16.1% |
| FY2020 | Jan 3, 2021 | $1.18B | +3.8% |
| FY2019 | Dec 29, 2019 | $1.14B | -42.9% |
| FY2018 | Dec 30, 2018 | $2.00B | +67.5% |
| FY2017 | Dec 31, 2017 | $1.19B | +12.7% |
| FY2016 | Jan 1, 2017 | $1.06B | -3.0% |
| FY2015 | Jan 3, 2016 | $1.09B | -15.5% |
| FY2014 | Dec 28, 2014 | $1.29B | +4308.1% |
| FY2013 | Dec 29, 2013 | $29.29M | -20.8% |
| FY2012 | Dec 30, 2012 | $36.97M | – |
| FY2011 | Jan 1, 2012 | $0 | -100.0% |
| FY2010 | Jan 2, 2011 | $311.61M | +7.4% |
| FY2009 | Jan 3, 2010 | $290.20M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | $1.79B | +80.0% |
| Q2 FY2026 | Jun 28, 2026 | $1.49B | -0.1% |
| Q1 FY2026 | Mar 29, 2026 | $1.49B | -0.1% |
| Q4 FY2025 | Dec 28, 2025 | $1.49B | 0.0% |
| Q3 FY2025 | Sep 28, 2025 | $994.00M | -50.0% |
| Q2 FY2025 | Jun 29, 2025 | $1.49B | +0.1% |
| Q1 FY2025 | Mar 30, 2025 | $1.49B | +0.1% |
| Q4 FY2024 | Dec 29, 2024 | $1.49B | +0.1% |
| Q3 FY2024 | Sep 29, 2024 | $1.99B | +33.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.49B | +0.1% |
| Q1 FY2024 | Mar 31, 2024 | $1.49B | +0.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.49B | +0.1% |
| Q3 FY2023 | Oct 1, 2023 | $1.49B | +200.8% |
| Q2 FY2023 | Jul 2, 2023 | $1.49B | +200.6% |
| Q1 FY2023 | Apr 2, 2023 | $1.49B | +198.0% |
| Q4 FY2022 | Jan 1, 2023 | $1.49B | +49.7% |
| Q3 FY2022 | Oct 2, 2022 | $495.00M | -58.2% |
| Q2 FY2022 | Jul 3, 2022 | $495.00M | -57.8% |
| Q1 FY2022 | Apr 3, 2022 | $499.00M | -57.1% |
| Q4 FY2021 | Jan 2, 2022 | $993.00M | -13.7% |
| Q4 FY2020 | Jan 3, 2021 | $1.18B | +3.8% |
| Q3 FY2020 | Sep 27, 2020 | $1.17B | +3.7% |
| Q2 FY2020 | Jun 28, 2020 | $1.16B | +3.8% |
| Q1 FY2020 | Mar 29, 2020 | $1.15B | -34.0% |
| Q4 FY2019 | Dec 29, 2019 | $1.14B | -42.9% |
| Q3 FY2019 | Sep 29, 2019 | $1.13B | -42.5% |
| Q2 FY2019 | Jun 30, 2019 | $1.12B | -16.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.74B | +31.1% |
| Q4 FY2018 | Dec 30, 2018 | $2.00B | +67.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.97B | +66.4% |
| Q2 FY2018 | Jul 1, 2018 | $1.35B | +14.8% |
| Q1 FY2018 | Apr 1, 2018 | $1.33B | +25.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.19B | +12.7% |
| Q3 FY2017 | Oct 1, 2017 | $1.18B | – |
| Q2 FY2017 | Jul 2, 2017 | $1.17B | – |
| Q1 FY2017 | Apr 2, 2017 | $1.06B | – |
| Q4 FY2016 | Jan 1, 2017 | $1.06B | – |
See a number that looks wrong?